Terbinafine-induced hepatitis and pancytopenia

Digestive Diseases and Sciences

Volumn 46, Issue 8, 2001, Pages 1714-1716

  Conjeevaram, Geetha ^a   Vongthavaravat, Verapan ^a   Sumner, Robert ^a   Koff, Raymond S ^b  

^a METROWEST MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aminotransferases; Hepatitis; Pancytopenia; Terbinafine

Indexed keywords

TERBINAFINE;

ACUTE HEPATITIS; ADULT; ARTICLE; BLOOD CELL COUNT; CASE REPORT; DRUG WITHDRAWAL; HUMAN; HYPERSENSITIVITY REACTION; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; MALE; PANCYTOPENIA; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PANCYTOPENIA;

EID: 0034897773     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010657605476     Document Type: Article

References (8)

1. Hepatitis associated with terbinafine therapy: Three case reports and a review of the literature
2. Terbinafine-associated hepatic injury
3. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts
4. Terbinafine-induced cholestatic liver disease
5. Hepatitis associated with terbinafine treatment
6. An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor
7. Neutropenia and pancytopenia associated with oral terbinafine